HEADER TRANSFERASE/INHIBITOR 07-MAY-15 4ZP5 TITLE MAP4K4 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1-309; COMPND 5 SYNONYM: HPK/GCK-LIKE KINASE HGK,MAPK/ERK KINASE KINASE KINASE 4, COMPND 6 MEKKK 4,NCK-INTERACTING KINASE; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP4K4, HGK, KIAA0687, NIK; SOURCE 6 EXPRESSION_SYSTEM: SIMULIUM SP. IRIDESCENT VIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10489 KEYWDS KINASE, INHIBITOR, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LIU REVDAT 2 06-MAR-24 4ZP5 1 REMARK REVDAT 1 05-OCT-16 4ZP5 0 JRNL AUTH S.LIU JRNL TITL STRUCTURE OF MAP4K4 COMPLEX JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 31343 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1588 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.37 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.66 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1680 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2924 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1601 REMARK 3 BIN R VALUE (WORKING SET) : 0.2905 REMARK 3 BIN FREE R VALUE : 0.3280 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 79 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4706 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 159 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.67 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.05360 REMARK 3 B22 (A**2) : -3.01310 REMARK 3 B33 (A**2) : -4.04050 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.449 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.348 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.241 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.343 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.243 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4842 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6553 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1703 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 121 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 692 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4842 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 621 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5429 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.57 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.03 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|14 - A|173 A|186 - A|309 A|400 - A|400 } REMARK 3 ORIGIN FOR THE GROUP (A): 73.4808 46.0907 11.3491 REMARK 3 T TENSOR REMARK 3 T11: -0.1821 T22: -0.2037 REMARK 3 T33: -0.1363 T12: 0.0089 REMARK 3 T13: 0.0451 T23: 0.0138 REMARK 3 L TENSOR REMARK 3 L11: 0.8797 L22: 3.5277 REMARK 3 L33: 1.9118 L12: 0.6551 REMARK 3 L13: 0.3719 L23: 1.5488 REMARK 3 S TENSOR REMARK 3 S11: -0.0123 S12: 0.0110 S13: 0.1041 REMARK 3 S21: -0.0047 S22: -0.0775 S23: 0.2256 REMARK 3 S31: -0.2544 S32: -0.0293 S33: 0.0898 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|10 - B|161 B|163 - B|309 } REMARK 3 ORIGIN FOR THE GROUP (A): 101.3220 32.7058 22.2977 REMARK 3 T TENSOR REMARK 3 T11: -0.1271 T22: -0.1340 REMARK 3 T33: -0.1318 T12: -0.0850 REMARK 3 T13: -0.0596 T23: -0.0565 REMARK 3 L TENSOR REMARK 3 L11: 2.2494 L22: 1.1584 REMARK 3 L33: 2.4452 L12: -0.3938 REMARK 3 L13: -0.8696 L23: 0.1662 REMARK 3 S TENSOR REMARK 3 S11: 0.0376 S12: -0.2176 S13: 0.2504 REMARK 3 S21: 0.2170 S22: 0.0879 S23: -0.1944 REMARK 3 S31: -0.2884 S32: 0.4489 S33: -0.1255 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZP5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000209648. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31533 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 97.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.46500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.31650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.76400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.69300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.76400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.31650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.69300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASN A 3 REMARK 465 ASP A 4 REMARK 465 SER A 5 REMARK 465 PRO A 6 REMARK 465 ALA A 7 REMARK 465 LYS A 8 REMARK 465 SER A 9 REMARK 465 LEU A 10 REMARK 465 VAL A 11 REMARK 465 ASP A 12 REMARK 465 ILE A 13 REMARK 465 VAL A 174 REMARK 465 SER A 175 REMARK 465 ALA A 176 REMARK 465 GLN A 177 REMARK 465 LEU A 178 REMARK 465 ASP A 179 REMARK 465 ARG A 180 REMARK 465 THR A 181 REMARK 465 VAL A 182 REMARK 465 GLY A 183 REMARK 465 ARG A 184 REMARK 465 ARG A 185 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ASN B 3 REMARK 465 ASP B 4 REMARK 465 SER B 5 REMARK 465 PRO B 6 REMARK 465 ALA B 7 REMARK 465 LYS B 8 REMARK 465 SER B 9 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER B 93 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 22 -77.34 -9.65 REMARK 500 VAL A 28 -63.75 -94.23 REMARK 500 ASN A 33 -10.94 -170.37 REMARK 500 PRO A 95 -18.56 -47.41 REMARK 500 HIS A 97 166.15 53.52 REMARK 500 ARG A 152 -11.09 75.16 REMARK 500 ASP A 153 50.92 -140.02 REMARK 500 ASN A 205 78.01 -114.10 REMARK 500 ASP A 207 76.02 -107.64 REMARK 500 LEU A 270 36.19 -94.08 REMARK 500 ASP B 12 -8.45 70.28 REMARK 500 ILE B 24 -57.62 -122.22 REMARK 500 VAL B 31 -77.89 -105.92 REMARK 500 GLN B 38 77.43 72.71 REMARK 500 LYS B 46 -77.51 -155.41 REMARK 500 THR B 47 91.42 -167.37 REMARK 500 LYS B 121 -102.12 42.23 REMARK 500 ARG B 152 -12.45 75.05 REMARK 500 ALA B 165 44.21 -77.10 REMARK 500 GLU B 204 -24.02 100.79 REMARK 500 ASP B 207 76.09 -108.30 REMARK 500 LEU B 270 43.69 -92.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4QG A 400 DBREF 4ZP5 A 1 309 UNP O95819 M4K4_HUMAN 1 309 DBREF 4ZP5 B 1 309 UNP O95819 M4K4_HUMAN 1 309 SEQRES 1 A 309 MET ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP ILE SEQRES 2 A 309 ASP LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE GLU SEQRES 3 A 309 LEU VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN VAL SEQRES 4 A 309 TYR LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA ALA SEQRES 5 A 309 ILE LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU GLU SEQRES 6 A 309 ILE LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER HIS SEQRES 7 A 309 HIS ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE LYS SEQRES 8 A 309 LYS SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU VAL SEQRES 9 A 309 MET GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU VAL SEQRES 10 A 309 LYS ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP ILE SEQRES 11 A 309 ALA TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA HIS SEQRES 12 A 309 LEU HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS GLY SEQRES 13 A 309 GLN ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS LEU SEQRES 14 A 309 VAL ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR VAL SEQRES 15 A 309 GLY ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP MET SEQRES 16 A 309 ALA PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP ALA SEQRES 17 A 309 THR TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY ILE SEQRES 18 A 309 THR ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU CYS SEQRES 19 A 309 ASP MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO ARG SEQRES 20 A 309 ASN PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER LYS SEQRES 21 A 309 LYS PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS ASN SEQRES 22 A 309 TYR MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS HIS SEQRES 23 A 309 PRO PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL ARG SEQRES 24 A 309 ILE GLN LEU LYS ASP HIS ILE ASP ARG THR SEQRES 1 B 309 MET ALA ASN ASP SER PRO ALA LYS SER LEU VAL ASP ILE SEQRES 2 B 309 ASP LEU SER SER LEU ARG ASP PRO ALA GLY ILE PHE GLU SEQRES 3 B 309 LEU VAL GLU VAL VAL GLY ASN GLY THR TYR GLY GLN VAL SEQRES 4 B 309 TYR LYS GLY ARG HIS VAL LYS THR GLY GLN LEU ALA ALA SEQRES 5 B 309 ILE LYS VAL MET ASP VAL THR GLU ASP GLU GLU GLU GLU SEQRES 6 B 309 ILE LYS LEU GLU ILE ASN MET LEU LYS LYS TYR SER HIS SEQRES 7 B 309 HIS ARG ASN ILE ALA THR TYR TYR GLY ALA PHE ILE LYS SEQRES 8 B 309 LYS SER PRO PRO GLY HIS ASP ASP GLN LEU TRP LEU VAL SEQRES 9 B 309 MET GLU PHE CYS GLY ALA GLY SER ILE THR ASP LEU VAL SEQRES 10 B 309 LYS ASN THR LYS GLY ASN THR LEU LYS GLU ASP TRP ILE SEQRES 11 B 309 ALA TYR ILE SER ARG GLU ILE LEU ARG GLY LEU ALA HIS SEQRES 12 B 309 LEU HIS ILE HIS HIS VAL ILE HIS ARG ASP ILE LYS GLY SEQRES 13 B 309 GLN ASN VAL LEU LEU THR GLU ASN ALA GLU VAL LYS LEU SEQRES 14 B 309 VAL ASP PHE GLY VAL SER ALA GLN LEU ASP ARG THR VAL SEQRES 15 B 309 GLY ARG ARG ASN THR PHE ILE GLY THR PRO TYR TRP MET SEQRES 16 B 309 ALA PRO GLU VAL ILE ALA CYS ASP GLU ASN PRO ASP ALA SEQRES 17 B 309 THR TYR ASP TYR ARG SER ASP LEU TRP SER CYS GLY ILE SEQRES 18 B 309 THR ALA ILE GLU MET ALA GLU GLY ALA PRO PRO LEU CYS SEQRES 19 B 309 ASP MET HIS PRO MET ARG ALA LEU PHE LEU ILE PRO ARG SEQRES 20 B 309 ASN PRO PRO PRO ARG LEU LYS SER LYS LYS TRP SER LYS SEQRES 21 B 309 LYS PHE PHE SER PHE ILE GLU GLY CYS LEU VAL LYS ASN SEQRES 22 B 309 TYR MET GLN ARG PRO SER THR GLU GLN LEU LEU LYS HIS SEQRES 23 B 309 PRO PHE ILE ARG ASP GLN PRO ASN GLU ARG GLN VAL ARG SEQRES 24 B 309 ILE GLN LEU LYS ASP HIS ILE ASP ARG THR HET 4QG A 400 21 HETNAM 4QG 4-[5-(4-CHLOROPHENYL)-1,3-OXAZOL-2-YL]BENZAMIDE FORMUL 3 4QG C16 H11 CL N2 O2 FORMUL 4 HOH *159(H2 O) HELIX 1 AA1 GLU A 62 SER A 77 1 16 HELIX 2 AA2 SER A 112 ASN A 119 1 8 HELIX 3 AA3 LYS A 126 HIS A 147 1 22 HELIX 4 AA4 LYS A 155 GLN A 157 5 3 HELIX 5 AA5 ALA A 196 ILE A 200 5 5 HELIX 6 AA6 ARG A 213 GLY A 229 1 17 HELIX 7 AA7 HIS A 237 ILE A 245 1 9 HELIX 8 AA8 SER A 259 LEU A 270 1 12 HELIX 9 AA9 ASN A 273 ARG A 277 5 5 HELIX 10 AB1 SER A 279 LYS A 285 1 7 HELIX 11 AB2 HIS A 286 ASP A 291 1 6 HELIX 12 AB3 ASN A 294 ARG A 308 1 15 HELIX 13 AB4 THR B 59 MET B 72 1 14 HELIX 14 AB5 ILE B 113 ASN B 119 1 7 HELIX 15 AB6 LYS B 126 HIS B 147 1 22 HELIX 16 AB7 LYS B 155 GLN B 157 5 3 HELIX 17 AB8 ALA B 196 ILE B 200 5 5 HELIX 18 AB9 ARG B 213 GLY B 229 1 17 HELIX 19 AC1 HIS B 237 ILE B 245 1 9 HELIX 20 AC2 SER B 259 LEU B 270 1 12 HELIX 21 AC3 ASN B 273 ARG B 277 5 5 HELIX 22 AC4 SER B 279 LYS B 285 1 7 HELIX 23 AC5 HIS B 286 ASP B 291 1 6 HELIX 24 AC6 ASN B 294 ARG B 308 1 15 SHEET 1 AA1 5 PHE A 25 VAL A 30 0 SHEET 2 AA1 5 VAL A 39 HIS A 44 -1 O LYS A 41 N GLU A 29 SHEET 3 AA1 5 LEU A 50 VAL A 58 -1 O ILE A 53 N TYR A 40 SHEET 4 AA1 5 ASP A 99 GLU A 106 -1 O LEU A 101 N MET A 56 SHEET 5 AA1 5 TYR A 85 LYS A 91 -1 N TYR A 86 O VAL A 104 SHEET 1 AA2 2 VAL A 159 LEU A 161 0 SHEET 2 AA2 2 VAL A 167 LEU A 169 -1 O LYS A 168 N LEU A 160 SHEET 1 AA3 5 PHE B 25 LEU B 27 0 SHEET 2 AA3 5 TYR B 36 HIS B 44 -1 O ARG B 43 N GLU B 26 SHEET 3 AA3 5 LEU B 50 VAL B 58 -1 O ILE B 53 N TYR B 40 SHEET 4 AA3 5 ASP B 99 GLU B 106 -1 O LEU B 101 N MET B 56 SHEET 5 AA3 5 TYR B 85 LYS B 91 -1 N PHE B 89 O TRP B 102 SHEET 1 AA4 3 GLY B 111 SER B 112 0 SHEET 2 AA4 3 VAL B 159 LEU B 161 -1 O LEU B 161 N GLY B 111 SHEET 3 AA4 3 VAL B 167 LEU B 169 -1 O LYS B 168 N LEU B 160 CISPEP 1 HIS A 97 ASP A 98 0 3.22 CISPEP 2 GLY B 37 GLN B 38 0 1.59 CISPEP 3 THR B 47 GLY B 48 0 2.72 CISPEP 4 SER B 93 PRO B 94 0 -1.85 CISPEP 5 GLY B 122 ASN B 123 0 -2.53 SITE 1 AC1 8 VAL A 31 TYR A 36 ALA A 52 GLU A 106 SITE 2 AC1 8 PHE A 107 CYS A 108 ASP A 115 LEU A 160 CRYST1 80.633 91.386 97.528 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012402 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010943 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010253 0.00000